Extraordinary Shareholders' Meeting, 11th December 2000

Extraordinary Shareholders' Meeting, 11th December 2000 The Nobel Biocare Board of Directors have today decided to hold an extraordinary Shareholders' Meeting on December 11th 2000, to discuss a proposal for some changes of the Board of Directors. The complete proposal will be announced in the Swedish newspapers Göteborgs-Posten, Svenska Dagbladet and Post & Inrikes Tidningar. Gothenburg, 25th October 2000 NOBEL BIOCARE AB Board of Directors Nobel Biocare is an innovative, medical devices company, whose core business comprises dental implants and dental prosthetics. The company's ® ® product systems for dental implants, Brånemark System and Steri-Oss , are world leaders and have a global market share of around 40%. ® The company's other product line, Procera , is a unique, IT-based process for the industrial production of dental prosthetics. The system has been launched very successfully in 22 countries. Nobel Biocare has around 1,190 employees and, in 1999, turnover totaled SEK 1 738 million. The company's headquarters are located in Gothenburg, Sweden, while production takes place in Sweden and the USA. Nobel Biocare has its own sales companies in 25 countries. ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2000/10/25/20001025BIT01040/bit0001.doc http://www.bit.se/bitonline/2000/10/25/20001025BIT01040/bit0002.pdf

About Us

Nobel Biocare is the world leader in innovative esthetic dental solutions with the brands Brånemark System® ,Replace® Select and Procera®.Nobel Biocare has around 1,300 employees and, in 2001 net sales totaled SEK 2 663 million. The company's headquarters are located in Gothenburg, Sweden. Nobel Biocare has its own sales organizations in 27 countries. The shares of the parent company Nobel Biocare Holding AG are listed on both the SWX Swiss Exchange and the Stockholm Stock Exchange.